LIVESTREAM: http://videoexchange.mayo.edu/webcasts

Headache
Ann M. Murray, M.D.
"Migraine Therapies: New Kids on the Block"

Learning Objectives
Upon conclusion of this activity, participants will be able to:

• Describe migraine pathophysiology and CGRP role
• Demonstrate understanding of the mechanism of migraine specific treatments (triptans, CGRP monoclonal antibodies)
• Recognize newer migraine specific treatments

Dr. Murray (nor spouse/partner) does not have any relevant financial relationship to disclose but does intend to discuss the following off-label/investigative use of a commercial product/devices:
Manufacturer Eli Lilly – Product Emgality, Manufacturer Amgen - Product Aimovig, and Manufacturer Teva – Product Ajovy.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.